PCDPrivate Comps Data

Company record · updated August 5, 2026

Apnimed, Inc.: 8 valuation observations from SEC filings

Every row below names the filing it came from. Coverage for this company runs July 10, 2026 to July 10, 2026.

8observations
1source filings
8verified rows
2026-07-10most recent as-of date

Source rails for this company: S-1 charter round (8).

As ofMeasureValueReported byTier What the filing saysAccession
2026-07-10 Series D-1 price per share 9.66 USD VERIFIED "Original Issue Price" defined for Series D-1 000119312526300909
2026-07-10 Series D price per share 9.66 USD VERIFIED "Original Issue Price" defined for Series D 000119312526300909
2026-07-10 Series C-3 price per share 4.7736 USD VERIFIED "Original Issue Price" defined for Series C-3 000119312526300909
2026-07-10 Series C-2 price per share 11.101 USD VERIFIED "Original Issue Price" defined for Series C-2 000119312526300909
2026-07-10 Series C-1 price per share 11.101 USD VERIFIED "Original Issue Price" defined for Series C-1 000119312526300909
2026-07-10 Series B price per share 8.8685 USD VERIFIED "Original Issue Price" defined for Series B 000119312526300909
2026-07-10 Series A-2 price per share 8.8685 USD VERIFIED "Original Issue Price" defined for Series A-2 000119312526300909
2026-07-10 Series A price per share 6.3854 USD VERIFIED "Original Issue Price" defined for Series A 000119312526300909

Reading these figures

A fund mark is the filer's own fair-value estimate at a quarter end, not a transaction price, and two filers can reach different values for the same date. A charter round price is the issue price of that series at issuance. Neither is a current market price. The capabilities page states the full limits.